A Study of EPEG in Beta Thalassemia Patients
NCT02950857
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
INDUSTRY
Sponsor class
Conditions
Beta-Thalassemia
Interventions
DRUG:
EPEG
Sponsor
Prolong Pharmaceuticals